AEGiS-WSJ: Drug Patents Draw Scrutiny As Bush Makes African Visit Wall Street JournalImportant note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Click here to return to Wall Street Journal main menu




DonateNow



Drug Patents Draw Scrutiny As Bush Makes African Visit

Wall Street Journal - July 9, 2003
Michael Schroeder, Staff Reporter


WASHINGTON -- In a five-nation African tour this week, President Bush is trumpeting his $15 billion program to fight the continent's AIDS epidemic. But that program's gains could be undercut by a separate U.S. effort to impose strict drug-patent protections that make AIDS drugs more expensive and harder to obtain.

The Commerce Department is helping shape patent laws in developing countries such as Nigeria -- where Mr. Bush will visit Saturday -- that go beyond global standards in protecting drug makers. The U.S. Trade Representative's office is seeking similarly strict protections in developing nations world-wide.

While President Bush is flaunting his program to help pay for drugs to treat AIDS in the near term in Africa, "there are many ways that the Bush administration has contravened the letter and spirit" of other global efforts to give needy countries better drug access, says Asia Russell, international policy coordinator at the Health Global Access Project, a nongovernmental activist group.
030709
WJ030704


Copyright © 2003 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .